These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15690597)

  • 1. Rheumatoid arthritis market.
    Mount C; Featherstone J
    Nat Rev Drug Discov; 2005 Jan; 4(1):11-2. PubMed ID: 15690597
    [No Abstract]   [Full Text] [Related]  

  • 2. NICE guidance on rheumatoid arthritis: implications and challenges for rheumatologists.
    Walker D; Hall S
    Rheumatology (Oxford); 2010 Apr; 49(4):619-20. PubMed ID: 20032225
    [No Abstract]   [Full Text] [Related]  

  • 3. Rheumatoid arthritis.
    Sutor SM; Gricar JA; Cave DG
    Manag Care Interface; 1999 Jun; 12(6):51-3. PubMed ID: 10538460
    [No Abstract]   [Full Text] [Related]  

  • 4. BSR and BHPR rheumatoid arthritis guidelines on eligibility criteria for the first biological therapy.
    Deighton C; Hyrich K; Ding T; Ledingham J; Lunt M; Luqmani R; Kiely P; Bukhari M; Abernethy R; Ostor A; Bosworth A; Gadsby K; McKenna F; Finney D; Dixey J;
    Rheumatology (Oxford); 2010 Jun; 49(6):1197-9. PubMed ID: 20308121
    [No Abstract]   [Full Text] [Related]  

  • 5. Modern drug treatment options for rheumatoid arthritis.
    Binning M
    Aust Nurs J; 2001 Apr; 8(9):suppl 1-3. PubMed ID: 11894377
    [No Abstract]   [Full Text] [Related]  

  • 6. Rituximab (Rituxan) for rheumatoid arthritis.
    Med Lett Drugs Ther; 2006 Apr; 48(1233):34-5. PubMed ID: 16625143
    [No Abstract]   [Full Text] [Related]  

  • 7. Making smart investment decisions in clinical research.
    Bansback N; Keystone E; O'Dell J; Phibbs CS; Hannagan K; Brophy M; Anis A
    Trials; 2015 Dec; 16():590. PubMed ID: 26712327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tacrolimus for therapy of rheumatoid arthritis].
    Harigai M
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():508-12. PubMed ID: 15799408
    [No Abstract]   [Full Text] [Related]  

  • 9. A case study on rheumatoid arthritis.
    Baker T
    Am J Manag Care; 2003 Sep; 9(4 Suppl):S87-98. PubMed ID: 14527109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rheumatoid arthritis: Developing new oral targeted therapies for RA can be challenging.
    Fleischmann RM
    Nat Rev Rheumatol; 2015 Jan; 11(1):4-6. PubMed ID: 25385416
    [No Abstract]   [Full Text] [Related]  

  • 11. Now that we know what's BeSt, what is good value for the money?
    Bansback N; Marra CA
    Arthritis Rheum; 2009 Mar; 61(3):289-90. PubMed ID: 19248126
    [No Abstract]   [Full Text] [Related]  

  • 12. Patient access to rheumatoid arthritis treatments.
    Jönsson B; Kobelt G; Smolen J
    Eur J Health Econ; 2008 Jan; 8 Suppl 2():S33-4. PubMed ID: 18097698
    [No Abstract]   [Full Text] [Related]  

  • 13. Rituximab for rheumatoid arthritis.
    Palylyk-Colwell E; McGahan L
    Issues Emerg Health Technol; 2006 Sep; (89):1-4. PubMed ID: 17014062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis: out of touch with clinical reality?
    Maetzel A
    Arthritis Rheum; 2005 Feb; 53(1):3-4. PubMed ID: 15696549
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cost effectiveness of pharmaceutical innovations. Health economic aspects of rheumatoid arthritis treatment with TNF-alpha antagonists].
    Kulp W; Greiner W; Graf von der Schulenburg JM
    Pharm Unserer Zeit; 2003; 32(5):420-5. PubMed ID: 14526463
    [No Abstract]   [Full Text] [Related]  

  • 16. Treat-to-target in rheumatoid arthritis: clinical and pharmacoeconomic considerations. Introduction.
    Turchetti G; Smolen JS; Kavanaugh A; Braun J; Pincus T; Bombardieri S
    Clin Exp Rheumatol; 2012; 30(4 Suppl 73):S1. PubMed ID: 23168235
    [No Abstract]   [Full Text] [Related]  

  • 17. A modest proposal.
    Lipsky PE
    Nat Clin Pract Rheumatol; 2006 Jul; 2(7):343. PubMed ID: 16932714
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluating treatment strategies in patients with early rheumatoid arthritis: merging modeling theory with clinical practice.
    Boonen A; Severens JL
    J Rheumatol; 2011 Aug; 38(8):1538-40. PubMed ID: 21807783
    [No Abstract]   [Full Text] [Related]  

  • 19. Costs of rheumatoid arthritis in Hungary.
    Péntek M; Kobelt G; Czirják L; Szekanecz Z; Poór G; Rojkovich B; Polgár A; Genti G; Kiss CG; Brodszky V; Májer I; Gulácsi L
    J Rheumatol; 2007 Jun; 34(6):1437. PubMed ID: 17552071
    [No Abstract]   [Full Text] [Related]  

  • 20. Deal watch : BMS acquires rights for IL-6 inhibitor.
    Nat Rev Drug Discov; 2010 Jan; 9(1):10. PubMed ID: 20043020
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.